According to the results of the competition ‘Conducting research by world-class scientific laboratories within the framework of the implementation of the priorities of scientific and technological development of the Russian Federation’ of the President’s program of research projects implemented by leading scientists, including young scientists, the Russian Science Foundation supported the project of the Federal State Budgetary Scientific Institution ‘Institute of Experimental Medicine’ ‘Creation of a bivalent vaccine against SARS-CoV-2 and influenza using a new technology platform’. Project manager – Head of the Laboratory of Immunology and Prevention of Viral Infections, Doctor of Biology I.N. Isakova-Sivak.